Should we expect novel biomarkers of myocardial infarction

Recent studies have revealed important roles for microRNAs (miRNAs) in cardiovascular disease, including acute myocardial infarction (AMI). miRNAs are small, 20–25 nucleotides long, non-coding RNA molecules, which inhibit gene expression by promoting mRNA degradation or preventing translation (1,2). Although the biological functions of miRNAs are not fully understood, numerous studies have shown that some miRNAs have unique expression profiles in certain tissues or cell types (3).